The gut microbiome, which can be affected by dietary and other "environmental" conditions, appears to have an important role in health and disease. A better understanding of the impact of changes in our gut microflora, as well as the determinants of these changes, represents an opportunity to address a number of acute and chronic disease conditions through novel mechanisms and therapeutic approaches.
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Recent advances in high-throughput metagenomic sequencing have provided a substantial body of knowledge regarding the gut microbiome and its potential relationship to disease. 1 Although the search for genetic explanations of chronic disease, such as diabetes and insulin resistance, continues, there exists growing interest in the epigenetic determinants of such conditions. The human genome consists of around 23,000 genes, whereas the gut microbiome contributes to approximately 3 million genes, representing over 99 % of our genetic makeup. 2 The specific composition of gut microbiota and their respective metabolites appears to be influenced by dietary intake and can either positively affect the host, such as through the production of butyrate, or contribute to toxicity, such as through the absorption of lipopolysaccharides. These changes appear to be, in part, associated with changes in the intestinal microflora composition and diversity. 3 For example, in type 2 diabetes, some studies have reported an increase in certain species of Firmicutes and a decrease in certain Bacteroidetes species, whose phyla collectively account for more than 90% of the gut microbiota. 4 Experiments in rodents have demonstrated an association between the gut microbiome and body weight, as well as insulin resistance and the development of diabetes. For example, germ-free mice gain less weight on a western high-fat diet than conventional mice, but transplantation of fecal material from the gut of conventional or obese animals to that of germ-free rodents induces weight gain and insulin resistance. 5 In addition, creating pseudo-germ-free mice via treatment with specific antibiotic "cocktails" to wipe out intestinal microflora can prevent the development of obesity in mice fed a high-fat diet, including leptin-deficient ob/ob mice. in germ-free mice recipients compared with no effect from stools collected before saccharin exposure.
A better understanding of the role of the gut microbiome in health and disease, and its effects on response or resistance to treatment, whether dietary, lifestyle, or pharmacologic, represents an exciting opportunity to affect health through novel pathways and pathophysiology. These preliminary and certainly provocative observations in the field of obesity and metabolic disturbances might be but harbingers of what might evolve in our quest to develop more targeted approaches to these challenging health matters. n
